Synergic combination of compositions containing aloe vera isolates and their therapeutic application

Synergic compositions containing an isolate and optionally, a prebiotic, Fucose, and/or other treatment regimens, as well as methods for their preparation and use in treating disease conditions such as neurological syndromes, chronic pai...

K Hann，L Lentz - US

USE OF TGF-BETA ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION

Effective use of a TGF-β antagonist to treat or to prevent loss of transplant function is described herein. Use of a TGF-β antagonist is demonstrated to effectively prevent loss of organ function in a host due to chronic rejection in w...

KESHAVJEE SHAF，ST. GEORGE JUDITH A.，LIU MINGYAO - EP

Antimicrobial combination therapy

Antimicrobial combination therapy.This invention provides methods and pharmaceutical compositions for treating a subject having a condition associated with an antibiotic resistant bacterial infection. The invention includes administering...

D Froim

USE OF TGF−β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION

Effective use of a TGF-β antagonist to treat or to prevent loss of transplant function is described herein. Use of a TGF-β antagonist is demonstrated to effectively prevent loss of organ function in a host due to chronic rejection in w...

S Keshavjee，George St., Judith A.，M Liu - WO

Pharmacologically Acceptable Salts of Clopidogrel

The invention relates to polymorphous forms of (+)-(S)-clopidogrel hydrogen bromide, described as polymorphous "form A", polymorphous "form B", polymorphous "form C", polymorphous "form D", polymorphous "form E", and polymorphous "form F...

Beat T. Weber，MK Levis，HQ Ly - US

Use of TGF-beta antagonists to treat or to prevent chronic transplant rejection

Effective use of a TGF-β antagonist to treat or to prevent loss of transplant function is described herein. Use of a TGF-β antagonist is demonstrated to effectively prevent loss of organ function in a host due to chronic rejection in w...

S Keshavjee，George St., Judith A.，M Liu

Antimicrobial combination therapy

This invention provides methods and pharmaceutical compositions for treating a subject having a condition associated with an antibiotic resistant bacterial infection. The invention includes administering to a subject a therapeutically ef...

D Froim，John M. Essigmann，Martin G. Marinus - US

Pharmaceutical dosage forms comprising descarboethoxyloratadine

Methods utilizing descarboethoxyloratadine (“DCL”) for the treatment of allergic disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines. Also included are...

DA Handley，PD Rubin - US

Composition to enhance joint function and repair

The present invention relates to a composition to enhance joint function, reduce inflammation and homocysteine levels, and repair cartilage. The present invention relates to a nutritional supplement comprising a glucosamine-containing co...

M Nelson - US

Compositions containing both sedative and non-sedative antihistamines

Compositions comprising both a sedative and a non-sedative antihistamine are disclosed as well as methods of inhibiting the release of histamines by administration of the compositions to a mammalian subject.

M Hirsh - WO